Sami-Sabinsa Group has opened a US$18bn facility in Hassan, in India’s Karnataka state.
The location's Unit 1, which covers an area of ten acres, was inaugurated on 17 March and is the company’s eighth manufacturing facility.
The unit will be dedicated to manufacturing 23 different active nutraceutical ingredients, as well as those for the pharmaceutical industry.
It has the capacity to produce 88 tons per annum for the global market.
Sami-Sabinsa’s Hassan facility is equipped with 18 reactors (including eight glass-line reactors), two hydrogenators and other specialised equipment.
“This is a milestone for the Sami-Sabinsa group,” said Dr Muhammed Majeed, Chairman and founder of Sami-Sabinsa Group.
“With preventive healthcare gaining more prominence worldwide, Sami-Sabinsa Group is gearing up with a new facility to support the wellness of mankind.
“Innovation and quality standards have always been the core pillars of our growth, which has mapped us globally.
“The Sami Nutraceuticals facility will be one of the cornerstones of our expansion strategy, enabling the company to bring more new innovations to market.”
